Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms
The epigenetic silencing of tumor suppressor genes (TSGs) is a common finding in several solid and hematological tumors involving various epigenetic readers and writers leading to enhanced cell proliferation and defective apoptosis. Thymoquinone (TQ), the major biologically active compound of black...
Main Authors: | Shahad A Qadi, Mohammed A Hassan, Ryan A Sheikh, Othman AS Baothman, Mazin A Zamzami, Hani Choudhry, Abdulrahman Labeed Al-Malki, Ashwag Albukhari, Mahmoud Alhosin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-04-01
|
Series: | Epigenetics Insights |
Online Access: | https://doi.org/10.1177/2516865719839011 |
Similar Items
-
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
by: Mahmoud Alhosin, et al.
Published: (2016-11-01) -
Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
by: Mahmoud Alhosin PhD, et al.
Published: (2020-09-01) -
Untargeted Metabolomics Identifies Key Metabolic Pathways Altered by Thymoquinone in Leukemic Cancer Cells
by: Asma Ahmed AlGhamdi, et al.
Published: (2020-06-01) -
Molecular profiling of epigenetic landscape of cancer cells during extracellular matrix detachment
by: Mohammad Imran Khan, et al.
Published: (2021-02-01) -
Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex
by: Omeima Abdullah, et al.
Published: (2021-04-01)